Table 5.
Treatment options of autonomic failures in Parkinson’s disease
| symptom | treatment options |
|---|---|
| salivation |
belladonna compounds, anticholinergic drugs, glycopyrrolate, botulinum toxin (off label use), 1% atropine eye solution (off label use) |
| seborrhea |
soaps, shampoos |
| hyperhidrosis |
botulinum toxin |
| constipation |
Various kinds of laxatives, sufficient hydration, fibers, prucaloprid (Reselor®), macrogel (Movicol®) |
| gastrointestinal motility |
Domperidone, prucaloprid (Reselor®) (off label use !) |
| bladder dysfunction |
genneral approach: reduced fluid intake at night is sometimes helpful. parasympatholytics, imipramine, Fesoterodinfumarat (Toviaz®) Darifenacin (Emselex ®), botulinum toxin (off label use !) (in case of imperative urgency due to overactive bladder syndrome [detrusor hyperreflexia or overactivity]) optimum dopaminergic drug titration (in case of frequent and/or involuntary urinary incontinence due to uninhibited contractions of the detrusor muscle) distigmine bromide, reduction of anticholinergic drugs, (in case of detrusor hyporeflexia [underactivity]) |
| sexual dysfunction |
sildenalfil, oral apomorphine, alprostadil, psychotherapy |
| orthostatic syndrome | patient education, non pharmacological interventions, midodrine, fludrocortisone, yohimbine, droxidopa |